ICTS News

Development of a metabolome-based respiratory infection prognostic during COVID-19 arrival

Jeffrey P. Henderson, MD, PhD, FIDSA
View Content

Jeffrey P. Henderson, MD, PhD, FIDSA, Professor of Medicine and Molecular Microbiology, at WashU Division of Infectious Diseases, was recently published in ASM Journals with new insights into the development of a metabolome-based respiratory infection prognostic during COVID-19.

Henderson highlights that the supportive environment at WashU Medicine played a crucial role in making this work possible, an aspect that is not explicitly mentioned in the article. Contributors include: John I. Robinson, Laura R. Marks, MDJane A. O’Halloran, MDWashU Medicine Division of Infectious Diseases. Along with: Charles W. Goss, PhD, Director, WashU Center for Biostatistics and Data Science, Andrew Hinton and Peter J. Mucha, Curriculum in Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill.